1785 related articles for article (PubMed ID: 33310781)
21. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.
Chang JC
Vasc Health Risk Manag; 2021; 17():273-298. PubMed ID: 34103921
[TBL] [Abstract][Full Text] [Related]
22. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
24. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors.
Targosz-Korecka M; Kubisiak A; Kloska D; Kopacz A; Grochot-Przeczek A; Szymonski M
Sci Rep; 2021 Jun; 11(1):12157. PubMed ID: 34108510
[TBL] [Abstract][Full Text] [Related]
25. ACE2 improves endothelial cell function and reduces acute lung injury by downregulating FAK expression.
He Y; Gang B; Zhang M; Bai Y; Wan Z; Pan J; Liu J; Liu G; Gu W
Int Immunopharmacol; 2024 Feb; 128():111535. PubMed ID: 38246001
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
27. The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
Abassi Z; Knaney Y; Karram T; Heyman SN
Front Immunol; 2020; 11():1312. PubMed ID: 32582222
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
29. COVID-19: Catastrophic Cause of Acute Lung Injury.
Cai A; McClafferty B; Benson J; Ramgobin D; Kalayanamitra R; Shahid Z; Groff A; Aggarwal CS; Patel R; Polimera H; Vunnam R; Golamari R; Sahu N; Bhatt D; Jain R
S D Med; 2020 Jun; 73(6):252-260. PubMed ID: 32580257
[TBL] [Abstract][Full Text] [Related]
30. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
[TBL] [Abstract][Full Text] [Related]
31. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
32. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
33. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
34. Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs.
Singh V; Beer A; Kraus A; Mang F; Zhang X; Xue J; Hagemann N; Hermann DM; Gunzer M
Brain Behav Immun; 2021 May; 94():458-462. PubMed ID: 33621620
[TBL] [Abstract][Full Text] [Related]
35. Single-cell expression profiles of
Lü M; Qiu L; Jia G; Guo R; Leng Q
Aging (Albany NY); 2020 Oct; 12(20):19880-19897. PubMed ID: 33104520
[TBL] [Abstract][Full Text] [Related]
36. Endothelial cells and SARS-CoV-2: An intimate relationship.
Barbosa LC; Gonçalves TL; de Araujo LP; Rosario LVO; Ferrer VP
Vascul Pharmacol; 2021 Apr; 137():106829. PubMed ID: 33422689
[TBL] [Abstract][Full Text] [Related]
37. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.
Yuan J; Fan D; Xue Z; Qu J; Su J
Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):13. PubMed ID: 33049061
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
39. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling.
Robles JP; Zamora M; Adan-Castro E; Siqueiros-Marquez L; Martinez de la Escalera G; Clapp C
J Biol Chem; 2022 Mar; 298(3):101695. PubMed ID: 35143839
[TBL] [Abstract][Full Text] [Related]
40. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
Pons S; Fodil S; Azoulay E; Zafrani L
Crit Care; 2020 Jun; 24(1):353. PubMed ID: 32546188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
